drugset / Trial / NCT03818282
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
Preliminary evaluation of the efficacy and safety of paclitaxel for injection (albumin-bound) in combination with carboplatin for first-line chemotherapy of ovarian cancer.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2023-06-30
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 260 mg/m2 | Intravenous |
| Background | Carboplatin | Small molecule | — | Intravenous |